Changes in soluble PD-L1 levels in patients with advanced non-small cell lung cancer

Changes in soluble PD-L1 levels in patients with advanced non-small cell lung cancer

Soluble programmed death-1 ligand (sPD-L1) in the serum of non-small cell lung cancer (NSCLC) patients is a crucial factor in disease prognosis and an indicator for immunotherapy response. This study aimed to evaluate changes in sPD-L1 levels in advanced NSCLC patients. Between May 2018 and October...

Full description

Saved in:
Bibliographic Details
Main Authors: Ta Thang Ba, Pham Nhung Thi Kim, Nguyen Dung Tien, Tran Tien Viet, Tran Cuong Tan, Cong Luong Thuc, Vu Hoan Ngoc, Le Hien Thi Dieu, Dao Bang Ngoc
Format: Article
Language:English
Published: Sciendo 2024-11-01
Series:Forum of Clinical Oncology
Subjects:
soluble pd-l1 (spd-l1)
membrane pd-l1 (mpd-l1)
non-small cell lung cancer (nsclc)
Online Access:https://doi.org/10.2478/fco-2023-0036
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.2478/fco-2023-0036

Similar Items